Ventures Ix, L.P.Healthcare... Net Worth

The estimated Net Worth of Ventures Ix, L.P.Healthcare... is at least $11.5 Milion dollars as of 5 February 2019. Ventures Healthcare owns over 571,428 units of Leap Therapeutics Inc stock worth over $11,481,107 and over the last 7 years Ventures sold LPTX stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ventures Healthcare LPTX stock SEC Form 4 insiders trading

Ventures has made over 2 trades of the Leap Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Ventures bought 571,428 units of LPTX stock worth $999,999 on 5 February 2019.

The largest trade Ventures's ever made was buying 1,057,769 units of Leap Therapeutics Inc stock on 14 November 2017 worth over $6,441,813. On average, Ventures trades about 407,299 units every 112 days since 2017. As of 5 February 2019 Ventures still owns at least 4,144,804 units of Leap Therapeutics Inc stock.

You can see the complete history of Ventures Healthcare stock trades at the bottom of the page.

Insiders trading at Leap Therapeutics Inc

Over the last 8 years, insiders at Leap Therapeutics Inc have traded over $0 worth of Leap Therapeutics Inc stock and bought 10,810,588 units worth $40,517,079 . The most active insiders traders include Advisors Llcperceptive Life..., Christopher Mirabelli oraz Ltd. Bei Gene,. On average, Leap Therapeutics Inc executives and independent directors trade stock every 142 days with the average trade being worth of $1,990,710. The most recent stock trade was executed by Christopher Mirabelli on 26 January 2024, trading 5,000 units of LPTX stock currently worth $13,850.

What does Leap Therapeutics Inc do?

leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com.

Complete history of Ventures Healthcare stock trades at Leap Therapeutics Inc

Leap Therapeutics Inc executives and stock owners

Leap Therapeutics Inc executives and other stock owners filed with the SEC include:

• Douglas Onsi,
  President, Chief Executive Officer, Director
• Augustine Lawlor,
  Chief Operating Officer
• Christopher Mirabelli,
  Chairman of the Board
• Cynthia Sirard,
  Chief Medical Officer
• Mark O'Mahony,
  Chief Manufacturing Officer
• Nissim Mashiach,
  Independent Director
• Joseph Loscalzo,
  Independent Director
• William Li,
  Independent Director
• Thomas Dietz,
  Lead Independent Director
• James Cavanaugh,
  Independent Director
• Monica Bertagnolli,
  Independent Director
• John W Littlechild,
  Director
• Ventures Ix, L.P.Healthcare...,
  
• Harold R Werner,
  10% owner
• Lilly & Co Eli,
  10% owner
• Patricia A. Martin,
  Director
• Christian M Richard,
  Director
• Richard Schilsky,
  Director
• Advisors Llcperceptive Life...,
  
• Ventures Viii, L.P.Health C...,
  
• Jason Baum,
  Chief Scientific Officer
• Christine Granfield,
  VP, Head of Reg Affairs/Qual
• Ltd. Bei Gene,,
  10% owner